PTGS2 and Alzheimer disease: The maximal ppRb and COX-2 immunoreactivity in stage A did not significantly differ from stage O. However, we did observe a significant decrease in Braak stage C compared to stage A. These findings contradict previous studies that have shown increased neuronal COX-2 expression [19,20] and ppRb immunoreactivity in AD cases [5].